医学部 精神医学講座

佐藤 謙伍

サトウ ケンゴ  (KENGO SATO)

基本情報

所属
自治医科大学 医学部 精神医学講座 助教

研究者番号
30807110
ORCID ID
 https://orcid.org/0009-0005-7677-3995
J-GLOBAL ID
202001012788040177
researchmap会員ID
R000009021

研究キーワード

 2

論文

 16
  • Yuki Matsuda, Shinsuke Kito, Fumiyo Hiraki, Takuji Izuno, Katsuomi Yoshida, Motoaki Nakamura, Fumitoshi Kodaka, Ryuichi Yamazaki, Nanase Taruishi, Shinichi Imazu, Tetsufumi Kanazawa, Takahiro Mekata, Sotaro Moriyama, Masataka Wada, Shinichiro Nakajima, Kazuyuki Sawada, Shinya Watanabe, Shun Takahashi, Yuuki Toi, Daisuke Hayashi, Shun Igarashi, Ko Fujiyama, Shunichiro Ikeda, Hiroshi Tateishi, Ryohei Kojima, Kengo Sato, Shuken Boku, Minoru Takebayashi, Moritaka Ogura, Atsuhiko Takaya, Kenji Endo, Akira Kita, Hisatoshi Arai, Hisashi Kamimura, Koji Matsuo, Kenzo Denda, Sachi Yamashiro, Daisuke Yoshioka, Junichiro Kizaki, Masaru Mimura, Yoshihiro Noda
    Psychiatry research 342 116263-116263 2024年11月10日  
    The objective of this study was to reveal the effectiveness of repetitive transcranial magnetic stimulation (rTMS) for Japanese patients with treatment-resistant depression (TRD) in clinical practice, based on real-world data from a nationwide multicenter observational study in Japan. Clinical data of patients with TRD treated with rTMS (NeuroStar TMS treatment system) under public insurance coverage were retrospectively collected from 21 institutes nationwide between June 2019 and December 2023. Depression severity was assessed by the 17-item Hamilton Depression Rating Scale (HAMD-17). Response and remission were defined as ≥50 % reduction from baseline and ≤7 points on the HAMD-17, respectively. The primary outcome was the changes in the HAMD-17 score from baseline to the endpoint following rTMS. Data from 497 patients with TRD were candidates for this study. The HAMD-17 scores (mean (SD)) improved significantly from 18.9 (5.3) to 9.7 (6.6), respectively. The response and remission rates at the end of rTMS therapy as assessed by the HAMD-17 were 53.5 % and 42.8 %, respectively. The dropout rate due to adverse effects was 4.2 %, and the treatment was generally well tolerated. No convulsive seizures or manic changes were observed. These results indicate that conventional rTMS is effective and safe in Japanese patients with TRD.
  • 佐藤謙伍, 塩田勝利, 塩田勝利, 岡田剛史, 安田学, 須田史朗
    総合病院精神医学 36(1) 2024年  
  • Kengo Sato, Ryosuke Watanabe, Tsuyoshi Okada, Yasushi Nishiyori, Toshiyuki Kobayashi, Shiro Suda
    PCN reports : psychiatry and clinical neurosciences 2(4) e154 2023年12月  
    BACKGROUND: Along with the improved prognosis of patients with congenital heart disease, the associated diverse complications are under scrutiny. Due to various medical restrictions on their upbringing, patients with congenital heart disease often have coexisting mental disorders. However, reports on patients with congenital heart disease and coexisting eating disorders are rare. Here, we report the case of a patient who developed anorexia nervosa (AN) following surgery for Ebstein's anomaly. CASE PRESENTATION: A 21-year-old female with Ebstein's anomaly who underwent Fontan surgery was transferred to our institution with suspected AN after >2 years of intermittent stays at a medical hospital for decreased appetite. Initially, she did not desire to lose weight or fear obesity, and we suspected that she was suffering from appetite loss due to a physical condition associated with Fontan circulation. However, the eating disorder pathology gradually became more apparent. CONCLUSION: Our experience suggests that patients with congenital heart disease are more likely to have a psychological background and physical problems that might contribute to eating disorders than the general population.
  • 安田学, 小林聡幸, 佐藤謙伍, 齋藤暢是, 須田史朗
    栃木精神医学 42 2022年  
  • 安田学, 小林聡幸, 佐藤謙伍, 齋藤暢是, 須田史朗
    栃木精神医学 42 2022年  

共同研究・競争的資金等の研究課題

 1

その他

 1